1. Home
  2. TSBX vs TNON Comparison

TSBX vs TNON Comparison

Compare TSBX & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSBX
  • TNON
  • Stock Information
  • Founded
  • TSBX 2015
  • TNON 2012
  • Country
  • TSBX United States
  • TNON United States
  • Employees
  • TSBX N/A
  • TNON N/A
  • Industry
  • TSBX
  • TNON Medical Specialities
  • Sector
  • TSBX
  • TNON Health Care
  • Exchange
  • TSBX Nasdaq
  • TNON Nasdaq
  • Market Cap
  • TSBX 7.7M
  • TNON 6.9M
  • IPO Year
  • TSBX 2023
  • TNON 2022
  • Fundamental
  • Price
  • TSBX $0.36
  • TNON $1.07
  • Analyst Decision
  • TSBX Buy
  • TNON Strong Buy
  • Analyst Count
  • TSBX 3
  • TNON 3
  • Target Price
  • TSBX $4.75
  • TNON $11.67
  • AVG Volume (30 Days)
  • TSBX 471.7K
  • TNON 176.5K
  • Earning Date
  • TSBX 08-13-2025
  • TNON 08-12-2025
  • Dividend Yield
  • TSBX N/A
  • TNON N/A
  • EPS Growth
  • TSBX N/A
  • TNON N/A
  • EPS
  • TSBX N/A
  • TNON N/A
  • Revenue
  • TSBX N/A
  • TNON $3,284,000.00
  • Revenue This Year
  • TSBX N/A
  • TNON $39.03
  • Revenue Next Year
  • TSBX N/A
  • TNON $66.24
  • P/E Ratio
  • TSBX N/A
  • TNON N/A
  • Revenue Growth
  • TSBX N/A
  • TNON 2.18
  • 52 Week Low
  • TSBX $0.29
  • TNON $0.85
  • 52 Week High
  • TSBX $2.65
  • TNON $15.79
  • Technical
  • Relative Strength Index (RSI)
  • TSBX 53.01
  • TNON 56.59
  • Support Level
  • TSBX $0.33
  • TNON $0.96
  • Resistance Level
  • TSBX $0.37
  • TNON $1.10
  • Average True Range (ATR)
  • TSBX 0.01
  • TNON 0.07
  • MACD
  • TSBX -0.00
  • TNON 0.01
  • Stochastic Oscillator
  • TSBX 74.50
  • TNON 67.10

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

About TNON Tenon Medical Inc.

Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

Share on Social Networks: